GENEA BIOCELLS PTY LTD

Shared Values
Mission: to supply and develop disease-specific human stem cells for medical research to advance treatment for
those disease sufferers.
Vision: To be world leader and partner of choice in the development and supply of disease-specific human stem cell
Strategy
lines and differentiated cells. Clearly defined ethical principles
Utilises human stem cells more accurate
environment
Unique stem cell medium
Only commercially available application-ready
differentiated disease specific cell types in world
Offers contract research services
Collaborative partnering with flexible approach
Commercialise existing products and services
Develop a stem-cell based discovery platform
Structure
Developing branding science humanised
Australian based, private unlisted company
Skills Diversifying its business
Highly specialised and experienced in Subsidiary of Genea Ltd
relevant fields, as well as technology Shareholders and equity partners doctors
and strategy/business and staff
Mainly PhD-level scientists in USA Draws on 30-year research heritage within
Dedicated Business Development Genea
team Obtains donated embryos from Genea
largest private bank of stem cells
Overseen by Human Ethics Committee
Style Partnership models and shared risk
Governed by same strong ethical principles Strategic expansion to USA 2015 (main
and corporate governance practices as market
Genea Exploring expansion into Europe
Only acts with full consent and within 3Systems
rd
of the 3 core business - integrated
Quality controls
regulations
Supply chain processes for worldwide
Compliance with highly regulated
delivery
environment and standards Australian and Staf
Will attract larger Shared governance and risk
international
talent pool now based management framework and controls
Gold Standard pluripotent stem cells
Culture of scientific excellence and innovationin USA